Literature DB >> 27725153

Deficits in the extinction of ethanol-seeking behavior following chronic intermittent ethanol exposure are attenuated with positive allosteric modulation of mGlu5.

J T Gass1, J T McGonigal2, L J Chandler2.   

Abstract

Alcoholism is a chronic relapsing disorder characterized by periods of heavy alcohol consumption and unsuccessful attempts at abstinence. Relapse is one of the most problematic aspects in the treatment of alcoholism and is triggered by ethanol-associated cues. Extinction-based cue exposure therapies have proven ineffective in the treatment of alcoholism. However, positive allosteric modulation of mGlu5 with CDPPB enhances the extinction learning of alcohol-seeking behavior. The current study investigated the impact of chronic alcohol exposure on the extinction of ethanol-seeking behavior. Adult Wistar rats were trained to self-administer alcohol with a light/tone stimulus serving as the alcohol cue. After training, one group of rats was exposed to chronic intermittent ethanol (CIE) daily for a period of 2 weeks to induce ethanol dependence. Control rats were exposed to air for the same period of time. Both groups were then retrained to self-administer ethanol and subsequently tested for changes in extinction learning. CIE exposed rats consumed more ethanol compared to their pre-CIE levels and to control rats. During extinction training, CIE rats responded significantly more on the previously active lever and required more sessions to reach extinction criteria compared to control rats. Treatment with CDPPB facilitated extinction in control rats and attenuated the increased resistance to extinction in CIE-exposed rats. These results demonstrate that chronic ethanol exposure not only alters ethanol intake, but also the extinction of ethanol-seeking behaviors. The ability to attenuate deficits through modulation of mGlu5 provides a potential target for pharmacological manipulation that could ultimately reduce relapse in alcoholics. Copyright Â
© 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Alcohol; Extinction; Glutamate; PFC; mGlu5

Mesh:

Substances:

Year:  2016        PMID: 27725153      PMCID: PMC5148675          DOI: 10.1016/j.neuropharm.2016.10.005

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  66 in total

1.  Extinction learning in humans: role of the amygdala and vmPFC.

Authors:  Elizabeth A Phelps; Mauricio R Delgado; Katherine I Nearing; Joseph E LeDoux
Journal:  Neuron       Date:  2004-09-16       Impact factor: 17.173

2.  The infralimbic cortex regulates the consolidation of extinction after cocaine self-administration.

Authors:  Ryan T LaLumiere; Kate E Niehoff; Peter W Kalivas
Journal:  Learn Mem       Date:  2010-03-23       Impact factor: 2.460

3.  Different neural substrates mediate cocaine seeking after abstinence versus extinction training: a critical role for the dorsolateral caudate-putamen.

Authors:  Rita A Fuchs; R Kyle Branham; Ronald E See
Journal:  J Neurosci       Date:  2006-03-29       Impact factor: 6.167

4.  Binge alcohol drinking by mice requires intact group 1 metabotropic glutamate receptor signaling within the central nucleus of the amygdala.

Authors:  Debra K Cozzoli; Justin Courson; Melissa G Wroten; Daniel I Greentree; Emily N Lum; Rianne R Campbell; Andrew B Thompson; Dan Maliniak; Paul F Worley; Georg Jonquieres; Matthias Klugmann; Deborah A Finn; Karen K Szumlinski
Journal:  Neuropsychopharmacology       Date:  2013-08-21       Impact factor: 7.853

5.  Enzymic ethanol assay: a new colorimetric method based on measurement of hydrogen peroxide.

Authors:  L Prencipe; E Iaccheri; C Manzati
Journal:  Clin Chem       Date:  1987-04       Impact factor: 8.327

6.  Working memory, executive processes and the effects of alcohol on Go/No-Go learning: testing a model of behavioral regulation and impulsivity.

Authors:  P R Finn; A Justus; C Mazas; J E Steinmetz
Journal:  Psychopharmacology (Berl)       Date:  1999-10       Impact factor: 4.530

7.  Stress hormone exposure reduces mGluR5 expression in the nucleus accumbens: functional implications for interoceptive sensitivity to alcohol.

Authors:  Joyce Besheer; Kristen R Fisher; Anel A Jaramillo; Suzanne Frisbee; Reginald Cannady
Journal:  Neuropsychopharmacology       Date:  2014-04-09       Impact factor: 7.853

8.  Role of dopamine, the frontal cortex and memory circuits in drug addiction: insight from imaging studies.

Authors:  Nora D Volkow; Joanna S Fowler; Gene-Jack Wang; Rita Z Goldstein
Journal:  Neurobiol Learn Mem       Date:  2002-11       Impact factor: 2.877

9.  Enhanced alcohol self-administration after intermittent versus continuous alcohol vapor exposure.

Authors:  Laura E O'Dell; Amanda J Roberts; Ron T Smith; George F Koob
Journal:  Alcohol Clin Exp Res       Date:  2004-11       Impact factor: 3.455

10.  The Plasticity of Extinction: Contribution of the Prefrontal Cortex in Treating Addiction through Inhibitory Learning.

Authors:  J T Gass; L J Chandler
Journal:  Front Psychiatry       Date:  2013-05-30       Impact factor: 4.157

View more
  10 in total

1.  Metabotropic Glutamate Receptors in Alcohol Use Disorder: Physiology, Plasticity, and Promising Pharmacotherapies.

Authors:  Max E Joffe; Samuel W Centanni; Anel A Jaramillo; Danny G Winder; P Jeffrey Conn
Journal:  ACS Chem Neurosci       Date:  2018-06-08       Impact factor: 4.418

Review 2.  Allosteric Modulation of GPCRs: New Insights and Potential Utility for Treatment of Schizophrenia and Other CNS Disorders.

Authors:  Daniel J Foster; P Jeffrey Conn
Journal:  Neuron       Date:  2017-05-03       Impact factor: 17.173

3.  Modulation of mGlu5 improves sensorimotor gating deficits in rats neonatally treated with quinpirole through changes in dopamine D2 signaling.

Authors:  Russell W Brown; Christopher G Varnum; Liza J Wills; Loren D Peeters; Justin T Gass
Journal:  Pharmacol Biochem Behav       Date:  2021-10-25       Impact factor: 3.697

4.  Optogenetic manipulation of the prelimbic cortex during fear memory reconsolidation alters fear extinction in a preclinical model of comorbid PTSD/AUD.

Authors:  C E Smiley; J T McGonigal; K E Nimchuk; J T Gass
Journal:  Psychopharmacology (Berl)       Date:  2021-08-04       Impact factor: 4.530

5.  The infralimbic cortex and mGlu5 mediate the effects of chronic intermittent ethanol exposure on fear learning and memory.

Authors:  C E Smiley; J T McGonigal; T Valvano; R J Newsom; N Otero; J T Gass
Journal:  Psychopharmacology (Berl)       Date:  2020-08-07       Impact factor: 4.530

Review 6.  Allosteric modulation of metabotropic glutamate receptors in alcohol use disorder: Insights from preclinical investigations.

Authors:  Kari A Johnson; David M Lovinger
Journal:  Adv Pharmacol       Date:  2020-03-02

7.  Chronic activation of fear engrams induces extinction-like behavior in ethanol-exposed mice.

Authors:  Christine Cincotta; Nathen J Murawski; Stephanie L Grella; Olivia McKissick; Emily Doucette; Steve Ramirez
Journal:  Hippocampus       Date:  2020-09-18       Impact factor: 3.899

8.  Effects of the Positive Allosteric Modulator of Metabotropic Glutamate Receptor 5, VU-29, on Maintenance Association between Environmental Cues and Rewarding Properties of Ethanol in Rats.

Authors:  Marta Marszalek-Grabska; Kinga Gawel; Dariusz Matosiuk; Ewa Gibula-Tarlowska; Joanna Listos; Jolanta H Kotlinska
Journal:  Biomolecules       Date:  2020-05-20

Review 9.  Therapeutic Interventions of Gut-Brain Axis as Novel Strategies for Treatment of Alcohol Use Disorder Associated Cognitive and Mood Dysfunction.

Authors:  Xin Li; Le-Mei Chen; Gajendra Kumar; Shan-Jin Zhang; Quan-Hai Zhong; Hong-Yan Zhang; Guan Gui; Lv-Le Wu; Hui-Zhen Fan; Jian-Wen Sheng
Journal:  Front Neurosci       Date:  2022-02-02       Impact factor: 4.677

10.  Impact of sex, strain, and age on blood ethanol concentration and behavioral signs of intoxication during ethanol vapor exposure.

Authors:  Elizabeth J Glover; Fauzan Khan; Kacey Clayton-Stiglbauer; L Judson Chandler
Journal:  Neuropharmacology       Date:  2020-11-19       Impact factor: 5.250

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.